Is TRXPF or DIVO a better dividend investment in 2026?

TRXPF currently yields 3.27% with a 5% 5-year dividend growth rate. DIVO yields 6.49% with 5% growth. The better choice depends on your goal: DIVO offers higher current income.

What is the dividend yield difference between TRXPF and DIVO?

TRXPF has a forward dividend yield of 3.27% ($0.80/share annually). DIVO yields 6.49% ($2.91/share annually). The yield gap is 3.22 percentage points.

Home › Compare › TRXPF vs DIVO

TRXPF vs DIVO: Dividend Comparison 2026

TRXPF yields 3.27% · DIVO yields 6.49%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 TRXPF wins by $634.91M in total portfolio value

INVESTMENT

TIME HORIZON10 years

TRXPF

● Live price

3.27%

Share price

$24.57

Annual div

$0.80

5Y div CAGR

100%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$634.94M

Annual income

$599,684,359.43

Full TRXPF calculator →

DIVO

● Live price

6.49%

Share price

$44.85

Annual div

$2.91

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$30.7K

Annual income

$981.68

Full DIVO calculator →

Portfolio growth — TRXPF vs DIVO

📍 TRXPF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	TRXPF	DIVO
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, TRXPF + DIVO cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

TRXPF pays

DIVO pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

TRXPF

Annual income on $10K today (after 15% tax)

$277.78/yr

After 10yr DRIP, annual income (after tax)

$509,731,705.52/yr

DIVO

Annual income on $10K today (after 15% tax)

$552.00/yr

After 10yr DRIP, annual income (after tax)

$834.43/yr

At 15% tax rate, TRXPF beats the other by $509,730,871.09/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of TRXPF + DIVO for your $10,000?

TRXPF: 50%DIVO: 50%

100% DIVO50/50100% TRXPF

Portfolio after 10yr

$317.48M

Annual income

$299,842,670.55/yr

Blended yield

94.44%

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

TRXPF buys

DIVO buys

No recent congressional trades found for TRXPF or DIVO in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricTRXPFDIVO

Forward yield	3.27%	6.49% ✓
Annual dividend / share	$0.80	$2.91 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	100% ✓	0%
Portfolio after 10y	$634.94M ✓	$30.7K
Annual income after 10y	$599,684,359.43 ✓	$981.68
Total dividends collected	$632.35M ✓	$8.2K
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: TRXPF vs DIVO ($10,000, DRIP)

Year	TRXPF Portfolio	TRXPF Income/yr	DIVO Portfolio	DIVO Income/yr	Gap
1← crossover	$11,354	$653.59	$11,349	$649.42	+$5.00 → TRXPF
2	$13,535	$1,387.04	$12,833	$688.83	+$702.00 → TRXPF
3	$17,574	$3,090.80	$14,459	$727.90	+$3.1K → TRXPF
4	$26,305	$7,500.82	$16,238	$766.49	+$10.1K → TRXPF
5	$49,132	$20,985.78	$18,179	$804.47	+$31.0K → TRXPF
6	$125,837	$73,265.77	$20,293	$841.71	+$105.5K → TRXPF
7	$485,391	$350,745.93	$22,591	$878.14	+$462.8K → TRXPF
8	$3,048,220	$2,528,851.81	$25,087	$913.65	+$3.02M → TRXPF
9	$32,945,707	$29,684,110.82	$27,791	$948.18	+$32.92M → TRXPF
10	$634,936,266	$599,684,359.43	$30,718	$981.68	+$634.91M → TRXPF

TRXPF vs DIVO: Complete Analysis 2026

TRXPF — Stock

Torii Pharmaceutical Co., Ltd. manufactures and markets pharmaceutical products in Japan. It offers therapeutic agents, such as Riona for the treatment of hyperphosphatemia; and REMITCH, an oral therapeutic agent used for the treatment of pruritus in dialysis and liver disease patients. The company also provides ANTEBATE that is used for the treatment of skin diseases, such as atopic dermatitis and contact dermatitis by reducing inflammation; allergen immunotherapy tablets comprising CEDARCURE and MITICURE; and CORECTIM, a topical janus kinase (JAK) inhibitor. It markets its products primarily through medical representatives for medical professionals. The company was formerly known as Torii Shoten K.K and changed its name to Torii Pharmaceutical Co., Ltd. in May 1949. The company was founded in 1872 and is headquartered in Tokyo, Japan. Torii Pharmaceutical Co., Ltd. is a subsidiary of Japan Tobacco Inc.

Full TRXPF Calculator →

DIVO — ETF

DIVO is an ETF of high-quality large cap companies with a history of dividend and earnings growth, along with a tactical covered call* strategy on individual stocks. DIVO is strategically designed to offer high levels of total return on a risk-adjusted basis.

Full DIVO Calculator →

📬

Get this TRXPF vs DIVO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

TRXPF vs SCHD TRXPF vs JEPI TRXPF vs O TRXPF vs KO TRXPF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.